May 20, 2024

Infectious Disease Diagnostics Market Size Analysis 2023 To 2032

The global infectious disease diagnostics market size accounted for US$ 28.65 Bn in 2022 and is projected to reach around USD 56.62 Bn by 2032, growing at a CAGR of 7.05% from 2023 to 2032.

Infectious Disease Diagnostics Market Size 2023 To 2032

Key Takeaways:

  • North America region is predicted to capture the largest market share between 2023 and 2032.
  • By Product, the assays & reagents segment generated more than 51% of revenue share in 2022.
  • By Technology, the immunodiagnostics segment is estimated to record the highest market share from 2023 to 2032.

Report Summary

The global infectious disease diagnostics market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the infectious disease diagnostics market across the globe.

A comprehensive estimate on the infectious disease diagnostics market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of infectious disease diagnostics during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3100

Infectious Disease Diagnostics Market Report Scope 

Report CoverageDetails
Market Size in 2023USD 30.67 Billion
Market Size by 2032USD 56.62 Billion
Growth Rate from 2023 to 2032CAGR of 7.05%
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Product, By Disease Type, and By Technology
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized infectious disease diagnostics market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Generative AI in Healthcare Market Size Analysis 2023 To 2032

Market Players

The report includes the profiles of key infectious disease diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Abbott Laboratories
  • Becton Dickinson and Company
  • bioMerieus SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F Hoffman-La Roche
  • Hologic Inc.
  • Luminex Corporation
  • Qiagen Inc.
  • Thermo Fisher Scientific Inc.

Infectious Disease Diagnostics Market Segmentation

By Product

  • Assays & Reagents
  • Instruments
  • Software

By Disease Type

  • Hepatitis
  • Human Immunodeficiency Virus
  • Influenza
  • Others

By Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction
  • Next-generation Sequencing
  • Others

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infectious Disease Diagnostics Market 

5.1. COVID-19 Landscape: Infectious Disease Diagnostics Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infectious Disease Diagnostics Market, By Product

8.1. Infectious Disease Diagnostics Market, by Product, 2023-2032

8.1.1 Assays & Reagents

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Instruments

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Software

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Infectious Disease Diagnostics Market, By Disease Type

9.1. Infectious Disease Diagnostics Market, by Disease Type, 2023-2032

9.1.1. Hepatitis

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Human Immunodeficiency Virus

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Influenza

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Infectious Disease Diagnostics Market, By Technology 

10.1. Infectious Disease Diagnostics Market, by Technology, 2023-2032

10.1.1. Immunodiagnostics

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Clinical Microbiology

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Polymerase Chain Reaction

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Next-generation Sequencing

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Infectious Disease Diagnostics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.1.3. Market Revenue and Forecast, by Technology (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Technology (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Technology (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.3. Market Revenue and Forecast, by Technology (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Technology (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Technology (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Technology (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Technology (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.3. Market Revenue and Forecast, by Technology (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Technology (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Technology (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Technology (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Technology (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.3. Market Revenue and Forecast, by Technology (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Technology (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Technology (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Technology (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Technology (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.5.3. Market Revenue and Forecast, by Technology (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Technology (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Disease Type (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Technology (2020-2032)

Chapter 12. Company Profiles

12.1. Abbott Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Becton Dickinson and Company

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. bioMerieus SA

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Bio-Rad Laboratories

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Danaher Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. F Hoffman-La Roche

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Hologic Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Luminex Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Qiagen Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Thermo Fisher Scientific Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com